Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
medicaid
4
×
national blog main
national top stories
novartis
4
×
boston blog main
boston top stories
clinical trials
gene therapy
johnson & johnson
national
new york blog main
new york top stories
spinal muscular atrophy
bill cassidy
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
mark warner
medicare
meiragtx
parkinson's disease
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
What
gene
alzheimer’s
bio
roundup
therapy
access
advanced
age
bigger
biggest
capacity
car
cell
come
companies
congress
consolidation
crispr
deal
democrats
different
divided
drug
elections
emerging
fail
falcon
fallout
focus
gave
increases
j
johnson
latest
losses
meiragtx
midterm
milestones
morning
panel
Language
unset
Current search:
medicaid
×
novartis
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
